2-73291607-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001965.4(EGR4):āc.1311T>Cā(p.Pro437=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00201 in 1,613,250 control chromosomes in the GnomAD database, including 56 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.011 ( 26 hom., cov: 33)
Exomes š: 0.0011 ( 30 hom. )
Consequence
EGR4
NM_001965.4 synonymous
NM_001965.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0810
Genes affected
EGR4 (HGNC:3241): (early growth response 4) Enables DNA-binding transcription activator activity, RNA polymerase II-specific and sequence-specific double-stranded DNA binding activity. Involved in positive regulation of transcription by RNA polymerase II. Predicted to be located in nucleoplasm. Predicted to be part of chromatin. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 2-73291607-A-G is Benign according to our data. Variant chr2-73291607-A-G is described in ClinVar as [Benign]. Clinvar id is 783333.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.081 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0107 (1622/152248) while in subpopulation AFR AF= 0.0372 (1543/41534). AF 95% confidence interval is 0.0356. There are 26 homozygotes in gnomad4. There are 770 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 26 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EGR4 | NM_001965.4 | c.1311T>C | p.Pro437= | synonymous_variant | 2/2 | ENST00000436467.4 | |
EGR4 | XM_047443603.1 | c.1308T>C | p.Pro436= | synonymous_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EGR4 | ENST00000436467.4 | c.1311T>C | p.Pro437= | synonymous_variant | 2/2 | 1 | NM_001965.4 | P2 | |
EGR4 | ENST00000545030.1 | c.1620T>C | p.Pro540= | synonymous_variant | 2/2 | 1 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0106 AC: 1614AN: 152130Hom.: 25 Cov.: 33
GnomAD3 genomes
AF:
AC:
1614
AN:
152130
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00262 AC: 652AN: 248598Hom.: 8 AF XY: 0.00177 AC XY: 239AN XY: 134730
GnomAD3 exomes
AF:
AC:
652
AN:
248598
Hom.:
AF XY:
AC XY:
239
AN XY:
134730
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00111 AC: 1616AN: 1461002Hom.: 30 Cov.: 32 AF XY: 0.000938 AC XY: 682AN XY: 726854
GnomAD4 exome
AF:
AC:
1616
AN:
1461002
Hom.:
Cov.:
32
AF XY:
AC XY:
682
AN XY:
726854
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0107 AC: 1622AN: 152248Hom.: 26 Cov.: 33 AF XY: 0.0103 AC XY: 770AN XY: 74442
GnomAD4 genome
AF:
AC:
1622
AN:
152248
Hom.:
Cov.:
33
AF XY:
AC XY:
770
AN XY:
74442
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
17
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 24, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at